Literature DB >> 15562733

Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.

H Karamifar1, M Shahriari, N Sadjadian.   

Abstract

To identify the prevalence of endocrine dysfunction in Iranians with beta-thalassaemia, we assessed thyroid, parathyroid, pancreatic and adrenal function in 150 beta-thalassaemic patients aged 10-22 years at the Paediatrics Unit, Shiraz University of Medical Sciences. Primary hypothyroidism was found in 6.0% of patients (mean age: 14.6 +/- 1.9 years), hypoparathyroidism in 7.3% (14.5 +/- 3.2 years), type 1 diabetes mellitus in 7.3% (13.9 +/- 2.8 years) and adrenal insufficiency in 1 patient. The relatively high frequency of endocrine dysfunction found in our study may be a result of poor disease control and management in early life when irreversible tissue damage occurs due to iron overload. These findings reinforce the importance of regular follow-up of patients with beta-thalassaemia major for early detection and management of associated complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15562733

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  9 in total

1.  Thyroid function in major thalassemia patients: Is it related to height and chelation therapy?

Authors:  Peiman Eshragi; Ahmad Tamaddoni; Khadijeh Zarifi; Amir Mohammadhasani; Majid Aminzadeh
Journal:  Caspian J Intern Med       Date:  2011

2.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Assessment of thyroid function in children aged 1-13 years with Beta-thalassemia major.

Authors:  Ayfer Gözü Pirinççioğlu; Turgay Deniz; Deniz Gökalp; Nurcan Beyazit; Kenan Haspolat; Murat Söker
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

Review 4.  Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.

Authors:  Adlette Inati; MohammadHassan A Noureldine; Anthony Mansour; Hussein A Abbas
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

5.  Evaluation of serum levels in T3, T4 and TSH in beta-thalassemic patients referred to the Abuzar hospital in Ahwaz.

Authors:  Zari Tahannejad Asad; Majid Ghazanfari; Seyyed Nima Naleini; Azam Sabagh; Wesam Kooti
Journal:  Electron Physician       Date:  2016-07-25

Review 6.  Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis study.

Authors:  Milad Azami; Ali Sharifi; Siros Norozi; Akram Mansouri; Kourosh Sayehmiri
Journal:  Caspian J Intern Med       Date:  2017

7.  Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran.

Authors:  Ali Bazi; Hadi Harati; Ali Khosravi-Bonjar; Elham Rakhshani; Mojtaba Delaramnasab
Journal:  Int J Endocrinol Metab       Date:  2018-02-10

8.  Thyroid Function in Chronically Transfused Children with Beta Thalassemia Major: A Cross-Sectional Hospital Based Study.

Authors:  Suraj Haridas Upadya; M S Rukmini; Sowmya Sundararajan; B Shantharam Baliga; Nutan Kamath
Journal:  Int J Pediatr       Date:  2018-09-16

9.  Detection of endocrine disorders in young children with multi-transfused thalassemia major.

Authors:  Ramadan A Mahmoud; Ashraf Khodeary; Marwa S Farhan
Journal:  Ital J Pediatr       Date:  2021-07-31       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.